AIQQX
Price
$21.27
Change
+$0.08 (+0.38%)
Updated
Jun 2 closing price
Net Assets
461.74M
VIVIX
Price
$83.17
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

AIQQX vs VIVIX

Header iconAIQQX vs VIVIX Comparison
Open Charts AIQQX vs VIVIXBanner chart's image
AIQQX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
AIQQX vs. VIVIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIQQX is a Hold and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 238B vs. AIQQX (462M). VIVIX pays higher dividends than AIQQX: VIVIX (1.87) vs AIQQX (1.62). AIQQX was incepted earlier than VIVIX: AIQQX (10 years) vs VIVIX (28 years). AIQQX (0.70) is less costly to investors than VIVIX (0.03). AIQQX is a more actively managed with annual turnover of: 13.00 vs. VIVIX (8.00). AIQQX has a lower initial minimum investment than VIVIX: AIQQX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 23.24 vs. AIQQX (-0.11). VIVIX return over 5 years is better than : 50.71 vs. AIQQX (16.34).
AIQQXVIVIXAIQQX / VIVIX
Total Expense Ratio0.690.032,300%
Annual Report Gross Expense Ratio0.700.032,333%
Fund Existence10 years28 years-
Gain YTD0.52210.6705%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets462M238B0%
Annual Yield % from dividends1.621.8786%
Returns for 1 year-0.1123.24-0%
Returns for 3 years23.9253.1845%
Returns for 5 years16.3450.7132%
Returns for 10 yearsN/A150.42-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFGC2.050.06
+3.02%
New Found Gold Corp
IMNN2.160.01
+0.47%
Imunon Inc
FE45.32-0.06
-0.13%
FirstEnergy Corp
TORO5.07-0.01
-0.14%
Toro Corp
VKTX29.29-1.98
-6.33%
Viking Therapeutics